Serevent Diskus
Serevent Diskus is an inhaled long-acting beta2-adrenergic agonist (LABA) bronchodilator. It helps keep the airways open, making breathing easier. It is used regularly to prevent bronchospasm but is not a rescue inhaler and should not be used to treat an acute asthma attack.
Dosage by Body Weight
The standard dose for adults and children 4 years of age and older is 1 inhalation (50 mcg) twice daily, approximately 12 hours apart. Dosage is not adjusted by body weight, and it is not recommended for children under 4 years of age.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in infants and young children under 4 years of age.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in infants and young children under 4 years of age.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in infants and young children under 4 years of age.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Generally corresponds to children under 4 years. Safety and efficacy have not been established.
- Body Weight
- 16-20 kg
- Dose
- 1 inhalation (50 mcg) twice daily
- Frequency
- Every 12 hours
- Tracking Notes
- Only if child is 4 years of age or older. Weight is not used for dosing; standard flat dose applies if prescribed.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and efficacy have not been established in infants and young children under 4 years of age. |
| 5-7 kg | Not recommended | Do not use | Safety and efficacy have not been established in infants and young children under 4 years of age. |
| 8-10 kg | Not recommended | Do not use | Safety and efficacy have not been established in infants and young children under 4 years of age. |
| 11-15 kg | Not recommended | Do not use | Generally corresponds to children under 4 years. Safety and efficacy have not been established. |
| 16-20 kg | 1 inhalation (50 mcg) twice daily | Every 12 hours | Only if child is 4 years of age or older. Weight is not used for dosing; standard flat dose applies if prescribed. |
Formulation
Purpose
Long-term maintenance treatment of asthma and prevention of bronchospasm in patients with reversible obstructive airway disease, and maintenance treatment of COPD-associated bronchospasm.
Generic Name
Salmeterol xinafoateScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.